Our mission
Translate protein measurements into predictive biology and reliable tools for research and clinical laboratories.
Company
Proteomics, AI and diagnostics.
One connected company.
Founded in Hangzhou in 2020, Westlake Omics brings together AI virtual cells, proteomics research services and clinical diagnostic technologies.
Our purpose and direction
Our vision
A future in which protein biology makes discovery more predictive and clinical testing more precise.
Company history
From protein measurements
to predictive biology.
Established in Hangzhou
Westlake Omics was founded in July 2020 to connect proteomics, AI and biomedical applications.
Expanding the experimental foundation
Research and clinical translation capabilities developed to support molecular diagnostics and pharmaceutical investigation.
Spatial proteomics research
Collaborative FAXP research published in Nature Communications adds tissue, cell and organelle context to protein measurement.
Protein-rich virtual cells
Proteomics-rich AIVC becomes a core scientific direction, alongside established research services and clinical products. Collaborative ProteinTalks research is published in Nature.
Our portfolio
Platforms, services and clinical products.
AIVC
Purpose-designed protein-state data, multimodal models and independent drug-research evaluation.
AI virtual cellsResearch services
Quantitative proteomics, spatial analysis, plasma enrichment, multi-omics and bioinformatics.
Browse servicesClinical diagnostics
Laboratory measurement and translational proteomics, including LMDx IGF-I and ThyroProt.
Clinical applicationsResearch partnerships
Contact Westlake Omics.
Connect with the right team for research, technology and diagnostic enquiries.